NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.25% | -3.22% | |||
| Total Other Revenue | 39.96% | 46.15% | |||
| Total Revenue | 6.69% | -0.93% | |||
| Cost of Revenue | -2.06% | -12.08% | |||
| Gross Profit | 8.61% | 1.92% | |||
| SG&A Expenses | 1.45% | 8.95% | |||
| Depreciation & Amortization | -2.53% | 6.67% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.44% | 3.90% | |||
| Operating Income | 80.49% | -36.05% | |||
| Income Before Tax | 72.22% | -31.99% | |||
| Income Tax Expenses | -0.61% | -3.77% | |||
| Earnings from Continuing Operations | 67.59% | -30.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 67.59% | -30.44% | |||
| EBIT | 80.49% | -36.05% | |||
| EBITDA | 39.99% | -17.53% | |||
| EPS Basic | 66.67% | -25.00% | |||
| Normalized Basic EPS | 89.47% | -38.71% | |||
| EPS Diluted | 41.67% | -14.29% | |||
| Normalized Diluted EPS | 82.35% | -41.38% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 9.54% | 0.26% | |||
| Dividend Per Share | -100.00% | -- | |||
| Payout Ratio | -0.40% | 16.56% | |||